Compare

Oscar Health/$OSCR

Oscar Health shares fall as investors question the sustainability of its Q3 profit and raised outlook, which included a $250 million favourable risk-adjustment benefit, while management flagged rising medical costs requiring 14% average premium increases for 2027.
2 hours agoLightyear AI
1D1W1M3M6MYTD1Y5YMAX

About Oscar Health

Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
Ticker
$OSCR
Sector
Finance
Primary listing
NYSE
Employees
2,305

Oscar Health Metrics

BasicAdvanced
$10B
12.05
$2.75
-
-

What the Analysts think about Oscar Health

Analyst ratings (Buy, Hold, Sell) for Oscar Health stock.
Analyst projections of the future price of Oscar Health stock.

Bulls say / Bears say

Oscar’s turnaround is now showing in reported results: Q3 operating earnings were $178 million versus a $129 million loss a year earlier, and the company raised its 2026 operating earnings outlook to $850–950 million. Lower medical and administrative expense ratios point to improving underwriting and cost control. (Oscar Health)
Membership rose 27% year on year to 2.7 million, while Oscar is expanding its footprint and expects to enter South Carolina in 2027. If it can convert this larger reach into well-priced policies, it has room to gain share in the individual market. (Oscar Health, Fierce Healthcare)
Oscar’s Lucie marketplace and CHOICE products could diversify growth beyond taking insurance risk. Lucie can earn fees and commissions by connecting customers with multiple carriers, while CHOICE gives Oscar a route into employer-funded individual cover. (Oscar Health, Yahoo Finance)
Oscar remains highly exposed to ACA policy and eligibility changes: it says the enhanced subsidies have expired and that tougher enrolment checks could shrink the market. Management expects to end 2026 with about 2.5 million members, below its 2.69 million at September’s end, as CMS eligibility reviews drive disenrolments. (Oscar Health, The Motley Fool)
Q3 revenue included a $250 million benefit from updated risk-adjustment estimates. Because this is an estimate that can change as market and member data develop, some of the quarter’s strength may not be repeatable. (Oscar Health, Oscar Health)
Medical cost pressure remains a risk: Oscar reported elevated outpatient use and set a roughly 14% weighted-average premium increase for 2027 to reflect higher medical trends and market morbidity. If claims costs rise faster than its pricing assumptions, margins could narrow. (The Motley Fool)
Data summarised monthly by Lightyear AI. Last updated on 6 Nov 2026.

Oscar Health Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Oscar Health Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing Oscar Health

AllUSDEURGBP
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.